Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica K Ortwine

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Hospital Practice (1995)|February 6, 2018
Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understandingJessica K Ortwine, Kavita Bhavan
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 29, 2014
Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literatureJessica K Ortwine, Jason M Pogue, Janie Faris
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 7, 2017
Ceftazidime/Avibactam: Who Says You Can't Teach an Old Drug New Tricks?Katie E Barber, Jessica K Ortwine, Ronda L Akins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2015
Optimal Usage of Colistin: Are We Any Closer?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
International Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Editorial Commentary: Colistin Dosing: Does the Fun Ever Start?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 26, 2013
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?Jessica K Ortwine, Brian J Werth, George Sakoulas, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Drugs|February 7, 2019
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial InfectionsKhalid Eljaaly, Aisha Alharbi, Samah Alshehri, et al.
Expert Review of Anti-Infective Therapy|July 18, 2015
Strategies for the safe use of colistinJessica K Ortwine, Jesse D Sutton, Keith S Kaye, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Hospital Practice (1995)|February 6, 2018
Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understandingJessica K Ortwine, Kavita Bhavan
Journal of Burn Care & Research : Official Publication of the American Burn Association|August 29, 2014
Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literatureJessica K Ortwine, Jason M Pogue, Janie Faris
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 7, 2017
Ceftazidime/Avibactam: Who Says You Can't Teach an Old Drug New Tricks?Katie E Barber, Jessica K Ortwine, Ronda L Akins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2015
Optimal Usage of Colistin: Are We Any Closer?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
International Journal of Antimicrobial Agents|November 24, 2016
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2016
Editorial Commentary: Colistin Dosing: Does the Fun Ever Start?Jason M Pogue, Jessica K Ortwine, Keith S Kaye
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 26, 2013
Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?Jessica K Ortwine, Brian J Werth, George Sakoulas, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Drugs|February 7, 2019
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial InfectionsKhalid Eljaaly, Aisha Alharbi, Samah Alshehri, et al.
Expert Review of Anti-Infective Therapy|July 18, 2015
Strategies for the safe use of colistinJessica K Ortwine, Jesse D Sutton, Keith S Kaye, et al.
Pageof 3